Catheter Precision Inc (AMEX: VTAK) – Analysts’ Revisions Point To Positive Sentiment

Catheter Precision Inc (AMEX:VTAK) traded at $0.53 at close of the session on Friday, January 03 and made an upward move of 18.01% on its previous day’s price.

Looking at the stock we see that its previous close was $0.45 with the day’s price range being $0.4276 – $0.56. In terms of its 52-week price range, VTAK has a high of $8.40 and a low of $0.31. The company’s stock has gained about 38.02% over that past 30 days.

Catheter Precision Inc has a market cap of $5.00 million and is expected to release its quarterly earnings report in February.

On the other hand, looking at the outlook for the VTAK stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 50% Sell.

Looking further, we note the current price level is 38.44% off its SMA20 and 18.76% from its 50-day simple moving average. The RSI (14) is pointing at 69.86 while the volatility over the past week is 16.34% and jumps to 12.48% over the past one month. The beta value is -0.36, while the average true range (ATR) is currently pointing at 0.06.

Coming back to Catheter Precision Inc (AMEX:VTAK), we note that the average 3-month trading volume was 3.57 million, while that of the preceding 10-day period stands at 0.51 million. Current shares outstanding are 8.00 million.

The insiders hold 2.18% of the company’s shares while institutions hold 2.02%. The data shows that short shares as of 2024-10-31, stood at 0.18 million at a short ratio of 0.02. This represents a 232.00 short interest in shares outstanding on 2024-10-31. Shares short rose in October from the previous month at 46547.0. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 17.52% up in year-to-date price movement.

Most Popular